Lab builds, expansions, and modernization across pathology, microbiology, molecular, chemistry/hematology, transfusion, and infection prevention—plus validation, operational readiness, and AI decision support aligned to LIS/EHR workflows.
Scalable capacity, standardized workflows, surge readiness, outbreak signal monitoring, and cross-border sourcing/logistics—under quality/data controls—while strengthening notifiable disease workflows, reference testing, and real-time surveillance.
Supply continuity for regulated equipment/consumables, documentation readiness, supplier qualification support, and risk-managed execution across regions—tracked with performance KPIs and early-warning indicators.
Cold-chain and high-value shipment planning, packaging and lane risk mitigation, exception management, and stakeholder coordination—protected by traceable chain-of-custody and excursion response playbooks.
Market entry and partnerships across North America and the GCC—hospital adoption enablement, implementation playbooks, and rollout management for diagnostics and AI (workflow fit, validation, monitoring, human-in-the-loop controls).
